智通财经网·2026-01-13 03:58Core Viewpoint - The report from Credit Lyonnais indicates that WuXi AppTec (02359) is expected to achieve a 9% revenue growth and a 36% increase in adjusted net profit for Q4 2025, surpassing market expectations by 2% and 3% respectively, driven by its strong CRDMO model and robust growth in WuXi TIDES business [1] Group 1: Financial Performance - WuXi AppTec's revenue for Q4 2025 is projected to grow by 9% [1] - Adjusted net profit for the same period is expected to increase by 36%, exceeding market expectations [1] - The company is anticipated to maintain a high double-digit growth in adjusted net profit for 2026, estimated between 16% to 19%, which is above the market expectation of 15% [1] Group 2: Market Position and Outlook - Credit Lyonnais has designated WuXi AppTec as the preferred stock in the Chinese CRO/CDMO sector, with a target price of HKD 143.4 and an "outperform" rating [1] - The report suggests that profitability will be more important than valuation expansion for the Chinese healthcare industry in 2026, with WuXi AppTec expected to outperform the market [1]